Vixarelimab

CAT: 0804-HY-P99519-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P99519-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) receptor β subunit monoclonal antibody. Vixarelimab inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash[1].
CAS Number
[2243320-83-2]
Product Name Alternative
KPL-716
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vixarelimab.html
Purity
96.90
Solubility
10 mM in DMSO
Smiles
[Vixarelimab]
Molecular Weight
(145.042 kDa)
References & Citations
[1]Carl D Richards, et al. Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716. Acta Derm Venereol. 2020 Jul 2;100 (14) :adv00197.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Related Products

CatalogName

Alternative Products

CatalogName
MBS5818881Vixarelimab
E55B0815Vixarelimab (Reference antibody)
C00740-01Vixarelimab (Anti-OSMR)
DHJ45501Research Grade Vixarelimab
047800OSMR (vixarelimab) discontinued
ICH5983-5mgVixarelimab Biosimilar - Research Grade
F1301-.1Anti-OSMR Antibody (Vixarelimab)
21-988Vixarelimab - Research Grade Biosimilar
MBS9247019-01Anti-OSMR Reference Antibody (vixarelimab)
MBS189350-01Anti-OSMR(vixarelimab biosimilar) mAb

Popular Products